OCP reports neuropathic progress in pre-clinical trials
Promising results reported from studies testing the efficacy of its lead compound.
Read morePromising results reported from studies testing the efficacy of its lead compound.
Read morePharma tech pioneer makes progress in bringing wide-ranging treatment to market.
Read moreMove could help to overcome challenges in accessing medical cannabis Down Under.
Read moreHaving acquired Vertigrow Technology in a deal valuing it at around £80m, AIM cash shell Summerway Capital has renamed as...
Read moreFormer boxer's plan to build a stable of celebrity branded products takes shape.
Read moreFunding boost for groundbreaking production technology.
Read moreColumbia Care is to be acquired by Cresco Labs in a deal which will create the world's "largest cannabis company...
Read moreA US-based cannabis events firm is harnessing the metaverse and non-fungible tokens (NFTs) to build its global audiences. Holders of...
Read moreAurora Cannabis is to acquire fellow Canadian firm Thrive for an initial value of US$38m plus earn out amounts over the...
Read moreMateria deal will accelerate listed firm's ongoing progress.
Read more© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.